Fig. 7From: Development of a necroptosis-related gene signature and the immune landscape in ovarian cancerImmune landscape based on the NRG signature. (A) Correlations between the immune cell infiltration in OC and two prognostic NRGs in the proposed model. (B) TME score in high- and low-risk groups. (C) Immune functions enriched in high- and low-risk groups. (D) TIDE score between high- and low-risk groups. (E) IC50 differences in cisplatin and (F) paclitaxelBack to article page